Reviewed clinical summary · Source-linked · Educational use only

Pilot RCT: Does an Integrated Intensive Exercise Protocol Improve Function in Adults with Obesity?

Hormone Insight clinical visual abstract for article 4412

Clinical Bottom Line

A small pilot randomised trial (n=30) testing whether an 8-week integrated intensive exercise protocol improves body composition, functional capacity and quality of life in young adults with obesity versus diet plus brisk walking. PICO summary and expert commentary.

Summary: In 30 young adults with obesity (BMI 30 to 39.9, aged 18 to 35), an 8-week Integrated Intensive Exercise Protocol (IIEP: aerobic, resistance and recreational training, 3 days per week) produced statistically significant improvements in body composition, 6-minute walk distance and quality of life compared with an active control arm of prescribed diet plus twice-daily brisk walking. This was a single-centre pilot randomised trial, and the abstract reports no effect sizes, confidence intervals or p-values, so the findings are exploratory rather than confirmatory.

PICO Summary

ElementDetail
Population30 adults with obesity (BMI 30 to 39.9 kg/m squared, aged 18 to 35). Single-centre pilot randomised controlled trial, India.
InterventionIntegrated Intensive Exercise Protocol (IIEP) combining aerobic exercise, resistance training and recreational activities, 3 days per week for 8 weeks (Group B, approximately n=15).
ComparisonActive control: prescribed diet plus brisk walking 30 minutes twice daily, 3 days per week for 8 weeks (Group A, approximately n=15).
OutcomeThe intervention group showed statistically significant improvements versus control in body composition (BMI), functional capacity (6-minute walk test) and quality of life (IWQOL-Lite). Both arms restored vital parameters (heart rate, respiratory rate, blood pressure) toward baseline to a similar degree. No effect sizes, 95% confidence intervals, p-values or ARR/NNT are reported in the abstract.

Expert Commentary

This is an early-stage, hypothesis-generating signal rather than practice-changing evidence. The verdict is cautiously positive but heavily qualified: a structured multi-component exercise programme outperformed diet plus walking on body composition, walking distance and quality of life in young, otherwise healthy adults with obesity. The headline weakness is that this was explicitly a pilot study of only 30 participants, and the published abstract reports no effect sizes, confidence intervals or p-values, so the magnitude and precision of benefit cannot be judged and the trial was almost certainly underpowered for firm conclusions. Short follow-up (8 weeks), a narrow age band and single-centre recruitment further limit how far the result can be generalised, and an unsupervised comparator makes it hard to separate the specific protocol from a simple dose-of-exercise effect. No industry or manufacturer sponsorship is apparent, and the effect, while described as significant, is not implausibly large. Can I use this with my patients? Not yet as a defined protocol. The reasonable takeaway is the familiar one, that supervised, varied, intensive training is plausibly better than walking alone for a motivated young adult, but this study does not establish a specific regimen, durability or safety in older or comorbid patients. A larger, adequately powered, longer trial reporting full statistics is needed before clinical adoption.

References

Sachdeva S, Rishi P, Pawaria S. Effectiveness of a Supervised 8-Week Structured Intensive Exercise Protocol on Functional Performance and Physiological Parameters in Adults With Obesity: An Experimental Study. Musculoskeletal Care. 2025;23(3):e70154. doi:10.1002/msc.70154

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.